Enviva Welcomes REDIII Agreement and Continued Recognition of Biomass[...]
EnLink Midstream Announces Pricing of Offering of $300.0 Million of[...]
Navidea Biopharmaceuticals Inc.
Navidea Biopharmaceuticals, Inc. Hires G2G Ventures as Executive[...]
NeuroBo Pharmaceuticals Reports Full Year 2022 Financial Results
Initial Registration Statement for Employee Benefit Plan - Form S-8
01/26/2023 | Press release | Distributed by Public on 01/26/2023 14:10
Please select the service you want to use: